HIBS is an exchange-traded fund, and — like most leveraged and inverse products — it has no meaningful analyst coverage or consensus price target. Benzinga, MarketBeat, and other data providers list "N/A" or "no recommendations" for the fund, which is typical for instruments designed as short-term trading tools rather than long-term holdings.
Because no analyst-derived target exists, the $23 objective used here reflects publicly discussed technical levels rather than a Wall Street consensus. The $22.64 upper bound of the fund's recent 50-day trading range and a prior resistance zone near $23.23 — a level cited in public chart commentary — provide a realistic, observable price objective. It is important to emphasize that $23 is a technical milestone grounded in market structure, not a forecast or a guarantee.
HIBS was recently changing hands near $19, at the lower end of a 52-week range of roughly $15.00 to $74.95. The fund began 2026 around $50 and has shed roughly 60% of its value year-to-date as high-beta equities rallied, illustrating how punishing a daily-reset inverse fund can be during a strong tape.
Moving from about $19 to $23 implies upside of roughly 20% — a substantial but not extreme move for a fund with this much volatility, yet one that requires a meaningful, sustained pullback in high-beta stocks rather than a single down day. Because the fund resets its -3x leverage daily, the path matters as much as the destination: choppy, sideways markets can erode value even if the underlying index does not trend higher.
The fund's fortunes are essentially the inverse of the market's most aggressive equities. The S&P 500 High Beta Index is heavily weighted toward information technology (roughly 43%), consumer discretionary (about 24%), and financials (about 12%), with names such as NVIDIA, ServiceNow, and semiconductor and solar equipment makers prominent among its constituents.
A rotation out of richly valued, high-beta growth stocks — triggered by, for example, higher-for-longer interest rates, disappointing tech earnings, or a broader risk-off move — would tend to lift HIBS. Its small asset base (around $20 million to $30 million in AUM) also means that relatively modest inflows can amplify short-term price moves.
The most significant obstacle is the prevailing trend itself. High-beta stocks have generally been in an uptrend, and any continuation of that momentum works directly against a -3x inverse fund. Compounding — often called volatility decay — is a structural headwind: even in a flat, choppy market, daily rebalancing can cause the fund to lose value over time.
Additional risks include the fund's elevated net expense ratio (roughly 1.06%), thin liquidity that can produce wider bid-ask spreads, and the inherent danger of holding leveraged inverse products beyond a single trading session. Investors should also remember that HIBS is a tactical trading vehicle, not a buy-and-hold position, and that its long-term record reflects severe losses during bull markets.
From a chart perspective, the area around $22.64 — the recent 50-day range high — represents the first meaningful resistance zone, with a prior resistance level near $23.23 sitting just above it. A decisive move through that band is what would put the $23 objective in play. On the downside, support appears near the low-to-mid $15 area, close to the fund's 52-week low. The broad $15-to-$75 trading range underscores the extreme volatility that makes precise entry and exit timing essential for this product.
Because HIBS has no analyst targets, there is no standardized research horizon attached to the $23 level; technical objectives like this are typically evaluated over days to weeks rather than a full year, reflecting the fund's short-term design. Investors should monitor the direction of the S&P 500's high-beta leaders, major technology earnings, Federal Reserve rate decisions, and inflation data, all of which can drive the sharp swings in sentiment that move this fund. Tracking fund flows and changes in the underlying index's composition can also provide useful signals.
Tickeron's AI Daily Buy/Sell Signals uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. For a fast-moving, leveraged instrument like HIBS, such tools can help traders discover opportunities, monitor positions, and spot changing trends more efficiently than manual screening. Traders interested in a more systematic approach may find value in reviewing these AI-generated signals alongside their own research.
Can HIBS reach $23? The question hinges on whether high-beta equities experience a pullback substantial enough to lift a -3x inverse fund by roughly 20%. The $23 level is a technical objective drawn from public chart discussion, not an analyst consensus, and it sits just above the fund's recent 50-day range high. The path is plausible during a risk-off rotation, but it faces a powerful headwind from the broader uptrend in high-beta growth stocks and the structural erosion of daily-reset leverage. Investors should treat any target for HIBS as a short-term, high-risk proposition and monitor high-beta earnings, interest-rate policy, and market sentiment closely rather than expecting a steady march toward the objective.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, HIBS has been closely correlated with PSQ. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if HIBS jumps, then PSQ could also see price increases.
| Ticker / NAME | Correlation To HIBS | 1D Price Change % | ||
|---|---|---|---|---|
| HIBS | 100% | +2.19% | ||
| PSQ - HIBS | 90% Closely correlated | -0.89% | ||
| SOXS - HIBS | 89% Closely correlated | +8.76% | ||
| TZA - HIBS | 87% Closely correlated | -4.42% | ||
| SDS - HIBS | 86% Closely correlated | -3.24% | ||
| SPXS - HIBS | 86% Closely correlated | -4.89% | ||
More | ||||